Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SpermVital’s patented technology encapsulates bovine sperm cells in a natural alginate gel before cryopreservation, enabling gradual release and extending the lifespan of viable sperm post-insemination from about 24 to up to 48 hours. This results in higher conception rates—up to an ~8% increase over conventional methods—greater flexibility for farmers regarding timing of insemination, reduced need for repeat procedures, improved animal welfare, and lower environmental impact. The product has been validated through multiple European trials showing significant improvements in non-return rates compared to standard semen.
The company’s solution has been adopted across Norway and exported internationally.
Research collaborations with academic institutions have further validated efficacy and contributed to ongoing innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SpermVital.